Delpharm is a leading CDMO :
- 18 plants in France, Italy, Canada, Poland and The Netherlands
- Over 1 billion euros turnover
- 6,000 people working in the company
- Most dosage forms produced
Over the last 30 years, the people of Delpharm have built a strong reputation of experienced professionals, supplying a wide range of most demanding customers. They are all committed to listen, be transparent and available, in order to make their customers benefit from their know how, acquired thought to the diversity of teams and experiences. The whole diversity of customers and successful projects over the past years have helped Delpharm to grow even more and gain in efficiency. This is all benefit in order to serve more and more customers.
Company Details
- Employees
- 39
- Address
- Zernikedreef 12, Leiden,zuid Holland 2333cl,netherlands
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Leiden, Zuid Holland
Delpharm Development Leiden Questions
Delpharm Development Leiden's LinkedIn profile is https://nl.linkedin.com/company/delpharm-leiden
Delpharm Development Leiden has
39 employees.
View email and phone details for 39
employees at Delpharm Development Leiden.
Delpharm Development Leiden's industry is
Pharmaceutical Manufacturing
Delpharm Development Leiden's top competitors are
Delpharm Bladel,
Teva Pharmaceuticals,
Delpharm Meppel,
Halix,
Galapagos,
Delpharm Saint Remy,
Proqr Therapeutics,
Johnson & Johnson,
Delpharm,
Batavia Biomanufacturing.
Delpharm Development Leiden's categories are Pharmaceutical Manufacturing
